{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:09:41Z","timestamp":1792271381566,"version":"4.4.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,3,19]],"date-time":"2016-03-19T00:00:00Z","timestamp":1458345600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s11060-016-2109-x","type":"journal-article","created":{"date-parts":[[2016,3,19]],"date-time":"2016-03-19T04:37:01Z","timestamp":1458362221000},"page":"293-302","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":74,"title":["Disseminated glioneuronal tumors occurring in childhood: treatment outcomes and BRAF alterations including V600E mutation"],"prefix":"10.1007","volume":"128","author":[{"given":"Andrew J.","family":"Dodgshun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"SantaCruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaeho","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shakti H.","family":"Ramkissoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayley","family":"Malkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Bergthold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Manley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duncan","family":"MacGregor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliana","family":"Goumnerova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Ligon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rameen","family":"Beroukhim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betty","family":"Herrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark W.","family":"Kieran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan R.","family":"Hansford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratiti","family":"Bandopadhayay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,19]]},"reference":[{"issue":"5","key":"2109_CR1","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00401-012-1037-x","volume":"124","author":"FJ Rodriguez","year":"2012","unstructured":"Rodriguez FJ, Perry A, Rosenblum MK, Krawitz S, Cohen KJ, Lin D, Mosier S, Lin MT, Eberhart CG, Burger PC (2012) Disseminated oligodendroglial-like leptomeningeal tumor of childhood: a distinctive clinicopathologic entity. Acta Neuropathol 124(5):627\u2013641","journal-title":"Acta Neuropathol"},{"issue":"2","key":"2109_CR2","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1750-3639.2009.00285.x","volume":"20","author":"MP Gardiman","year":"2010","unstructured":"Gardiman MP, Fassan M, Orvieto E, D\u2019Avella D, Denaro L, Calderone M, Severino M, Scarsello G, Viscardi E, Perilongo G (2010) Diffuse leptomeningeal glioneuronal tumors: a new entity? Brain Pathol 20(2):361\u2013366","journal-title":"Brain Pathol"},{"issue":"6","key":"2109_CR3","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1177\/0883073811426500","volume":"27","author":"DP Agamanolis","year":"2012","unstructured":"Agamanolis DP, Katsetos CD, Klonk CJ, Bartkowski HM, Ganapathy S, Staugaitis SM, Kuerbitz SJ, Patton DF, Talaizadeh A, Cohen BH (2012) An unusual form of superficially disseminated glioma in children: report of 3 cases. J Child Neurol 27(6):727\u2013733","journal-title":"J Child Neurol"},{"key":"2109_CR4","first-page":"1122","volume":"21","author":"DM Armao","year":"2000","unstructured":"Armao DM, Stone J, Castillo M, Mitchell KM, Bouldin TW, Suzuki K (2000) Diffuse leptomeningeal oligodendrogliomatosis: radiologic\/pathologic correlation. Am J Neuroradiol 21:1122\u20131126","journal-title":"Am J Neuroradiol"},{"issue":"Suppl. 6","key":"2109_CR5","first-page":"465","volume":"105","author":"TD Bourne","year":"2006","unstructured":"Bourne TD, Mandell JW, Matsumoto JA, Jane JA Jr, Lopes MB (2006) Primary disseminated leptomeningeal oligodendroglioma with 1p deletion. Case report. J Neurosurg 105(Suppl. 6):465\u2013469","journal-title":"J Neurosurg"},{"key":"2109_CR6","doi-asserted-by":"crossref","first-page":"724","DOI":"10.3171\/jns.1995.83.4.0724","volume":"83","author":"R Chen","year":"1995","unstructured":"Chen R, Macdonald DR, Ramsay DA (1995) Primary diffuse leptomeningeal oligodendroglioma. Case report. J Neurosurg 83:724\u2013728","journal-title":"J Neurosurg"},{"issue":"1","key":"2109_CR7","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11060-015-1735-z","volume":"124","author":"M Preuss","year":"2015","unstructured":"Preuss M, Christiansen H, Merkenschlager A, Hirsch FW, Kiess W, M\u00fcller W, K\u00e4stner S, Henssler A, Pekrun A, Hauch H, Nathrath M, Meixensberger J, Pietsch T, Kuchelmeister K (2015) Disseminated oligodendroglial cell-like leptomeningeal tumors: preliminary diagnostic and therapeutic results for a novel tumor entity. J Neurooncol 124(1):65\u201374","journal-title":"J Neurooncol"},{"key":"2109_CR8","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1007\/s00018-011-0898-9","volume":"69","author":"DT Jones","year":"2012","unstructured":"Jones DT, Gronych J, Lichter P, Witt O, Pfister SM (2012) MAPK pathway activation in pilocytic astrocytoma. Cell Mol Life Sci 69:1799\u20131811","journal-title":"Cell Mol Life Sci"},{"issue":"8","key":"2109_CR9","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/ng.2682","volume":"45","author":"DT Jones","year":"2013","unstructured":"Jones DT, Hutter B, J\u00e4ger N, Korshunov A, Kool M, Warnatz HJ et al (2013) Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma. Nat Genet 45(8):927\u2013932","journal-title":"Nat Genet"},{"issue":"2","key":"2109_CR10","first-page":"294","volume":"1845","author":"G Bergthold","year":"2014","unstructured":"Bergthold G, Bandopadhayay P, Bi WL, Ramkissoon L, Stiles C, Segal RA, Beroukhim R, Ligon KL, Grill J, Kieran MW (2014) Pediatric low-grade gliomas: how modern biology reshapes the clinical field. Biochim Biophys Acta 1845(2):294\u2013307","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"2109_CR11","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/ng.2611","volume":"45","author":"J Zhang","year":"2013","unstructured":"Zhang J, Wu G, Miller CP, Tatevossian RG, Dalton JD, Tang B et al (2013) Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas. Nat Genet 45(6):602\u2013612","journal-title":"Nat Genet"},{"issue":"7","key":"2109_CR12","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1002\/pbc.24958","volume":"61","author":"P Bandopadhayay","year":"2014","unstructured":"Bandopadhayay P, Bergthold G, London WB, Goumnerova LC, Morales La Madrid A, Marcus KJ, Guo D, Ullrich NJ, Robison NJ, Chi SN, Beroukhim R, Kieran MW, Manley PE (2014) Long-term outcome of 4,040 children diagnosed with pediatric low-grade gliomas: an analysis of the Surveillance Epidemiology and End Results (SEER) database. Pediatr Blood Cancer 61(7):1173\u20131179","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"2109_CR13","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/2051-5960-2-18","volume":"2","author":"K Gupta","year":"2014","unstructured":"Gupta K, Orisme W, Harreld JH, Qaddoumi I, Dalton JD, Punchihewa C, Collins-Underwood R, Robertson T, Tatevossian RG, Ellison DW (2014) Posterior fossa and spinal gangliogliomas form two distinct clinicopathologic and molecular subgroups. Acta Neuropathol Commun 2(1):18","journal-title":"Acta Neuropathol Commun"},{"issue":"3","key":"2109_CR14","doi-asserted-by":"crossref","first-page":"e17948","DOI":"10.1371\/journal.pone.0017948","volume":"6","author":"D Dias-Santagata","year":"2011","unstructured":"Dias-Santagata D, Lam Q, Vernovsky K, Vena N, Lennerz JK, Borger DR, Batchelor TT, Ligon KL, Iafrate AJ, Ligon AH, Louis DN, Santagata S (2011) BRAF V600E mutations are common in pleomorphic xanthroastrocytoma: diagnostic and therapeutic implications. PLoS One 6(3):e17948","journal-title":"PLoS One"},{"issue":"3","key":"2109_CR15","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00401-011-0802-6","volume":"121","author":"G Schindler","year":"2011","unstructured":"Schindler G, Capper D, Meyer J, Janzarik W, Omran H, Herold-Mende C, Schmieder K, Wesseling P, Mawrin C, Hasselblatt M, Louis DN, Korshunov A, Pfister S, Hartmann C, Paulus W, Reifenberger G, von Deimling A (2011) Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma. Acta Neuropathol 121(3):397\u2013405","journal-title":"Acta Neuropathol"},{"issue":"4","key":"2109_CR16","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/sj.bjc.6605179","volume":"101","author":"K Jacob","year":"2009","unstructured":"Jacob K, Albrecht S, Sollier C, Faury D, Sader E, Montpetit A, Serre D, Hauser P, Garami M, Bognar L, Hanzely Z, Montes JL, Atkinson J, Farmer JP, Bouffet E, Hawkins C, Tabori U, Jabado N (2009) Duplication of 7q34 is specific to juvenile pilocytic astrocytomas and a hallmark of cerebellar and optic pathway tumours. Br J Cancer 101(4):722\u2013733","journal-title":"Br J Cancer"},{"issue":"6","key":"2109_CR17","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/j.1750-3639.2012.00601.x","volume":"22","author":"YH Kim","year":"2012","unstructured":"Kim YH, Nonoguchi N, Paulus W, Brokinkel B, Keyvani K, Sure U, Wrede K, Mariani L, Giangaspero F, Tanaka Y, Nakazato Y, Vital A, Mittelbronn M, Perry A, Ohgaki H (2012) Frequent BRAF gain in low-grade diffuse gliomas with 1p\/19q loss. Brain Pathol 22(6):834\u2013840","journal-title":"Brain Pathol"},{"key":"2109_CR18","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/1471-2407-14-258","volume":"14","author":"GW Robinson","year":"2014","unstructured":"Robinson GW, Orr BA, Gajjar A (2014) Complete clinical regression of a BRAF V600E-mutant pediatric glioblastoma multiforme after BRAF inhibitor therapy. BMC Cancer 14:258","journal-title":"BMC Cancer"},{"issue":"6","key":"2109_CR19","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/pbc.24891","volume":"61","author":"F Bautista","year":"2014","unstructured":"Bautista F, Paci A, Minard-Colin V, Dufour C, Grill J, Lacroix L, Varlet P, Valteau-Couanet D, Geoerger B (2014) Vemurafenib in pediatric patients with BRAFV600E mutated high-grade gliomas. Pediatr Blood Cancer 61(6):1101\u20131103","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"2109_CR20","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s11060-013-1176-5","volume":"114","author":"MC Chamberlain","year":"2013","unstructured":"Chamberlain MC (2013) Salvage therapy with BRAF inhibitors for recurrent pleomorphic xanthoastrocytoma: a retrospective case series. J Neurooncol 114(2):237\u2013240","journal-title":"J Neurooncol"},{"issue":"1\u20132","key":"2109_CR21","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jns.2009.08.047","volume":"287","author":"A Michotte","year":"2009","unstructured":"Michotte A, Chaskis C, Sadones J, Veld PI, Neyns B (2009) Primary leptomeningeal anaplastic oligodendroglioma with a 1p36-19q13 deletion: report of a unique case successfully treated with Temozolomide. J Neurol Sci. 287(1\u20132):267\u2013270","journal-title":"J Neurol Sci."},{"issue":"4","key":"2109_CR22","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1159\/000317261","volume":"46","author":"SL Hervey-Jumper","year":"2010","unstructured":"Hervey-Jumper SL, Jumper M, Blaivas M, Parmar HA, Robertson PL, Maher CO (2010) Primary diffuse leptomeningeal oligodendroglioma. Paediatr Neurosurg 46(4):326\u2013328","journal-title":"Paediatr Neurosurg"},{"issue":"4","key":"2109_CR23","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s00401-015-1400-9","volume":"129","author":"FJ Rodriguez","year":"2015","unstructured":"Rodriguez FJ, Schniederjan MJ, Nicolaides T, Tihan T, Burger PC, Perry A (2015) High rate of concurrent BRAF-KIAA1549 gene fusion and 1p deletion in disseminated oligodendroglioma-like leptomeningeal neoplasms (DOLN). Acta Neuropathol 129(4):609\u2013610","journal-title":"Acta Neuropathol"},{"issue":"21","key":"2109_CR24","doi-asserted-by":"crossref","first-page":"8673","DOI":"10.1158\/0008-5472.CAN-08-2097","volume":"68","author":"DT Jones","year":"2008","unstructured":"Jones DT, Kocialkowski S, Liu L, Pearson DM, B\u00e4cklund LM, Ichimura K, Collins VP (2008) Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas. Cancer Res 68(21):8673\u20138677","journal-title":"Cancer Res"},{"issue":"8","key":"2109_CR25","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/bjc.2015.75","volume":"112","author":"CP Kratz","year":"2015","unstructured":"Kratz CP, Franke L, Peters H, Kohlschmidt N, Kazmierczak B, Finckh U, Bier A, Eichhorn B, Blank C, Kraus C, Kohlhase J, Pauli S, Wildhardt G, Kutsche K, Auber B, Christmann A, Bachmann N, Mitter D, Cremer FW, Mayer K, Daumer-Haas C, Nevinny-Stickel-Hinzpeter C, Oeffner F, Schl\u00fcter G, Gencik M, \u00dcberlacker B, Lissewski C, Schanze I, Greene MH, Spix C, Zenker M (2015) Cancer spectrum and frequency among children with Noonan, Costello, and cardio-facio-cutaneous syndromes. Br J Cancer 112(8):1392\u20131397","journal-title":"Br J Cancer"},{"issue":"5765","key":"2109_CR26","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1126\/science.1124642","volume":"311","author":"P Rodriguez-Viciana","year":"2006","unstructured":"Rodriguez-Viciana P, Tetsu O, Tidyman WE, Estep AL, Conger BA, Cruz MS, McCormick F, Rauen KA (2006) Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome. Science 311(5765):1287\u20131290","journal-title":"Science"},{"issue":"15","key":"2109_CR27","doi-asserted-by":"crossref","first-page":"5957","DOI":"10.1073\/pnas.1219232110","volume":"110","author":"A Sievert","year":"2013","unstructured":"Sievert A, Lang SS, Boucher KL, Madsen PJ, Slaunwhite E, Choudhari N, Kellet M, Storm PB, Resnick AC (2013) Paradoxical activation and RAF inhibitor resistance of BRAF protein kinase fusions characterizing pediatric astrocytomas. Proc Natl Acad Sci USA 110(15):5957\u20135962","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"2109_CR28","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1093\/neuonc\/nou059","volume":"16","author":"MA Karajannis","year":"2014","unstructured":"Karajannis MA, Legault G, Fisher MJ, Milla SS, Cohen KJ, Wisoff JH et al (2014) Phase II study of sorafenib in children with recurrent or progressive low-grade astrocytomas. Neuro Oncol 16(10):1408\u20131416","journal-title":"Neuro Oncol"},{"issue":"6892","key":"2109_CR29","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","volume":"417","author":"H Davies","year":"2002","unstructured":"Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S et al (2002) Mutations of the BRAF gene in human cancer. Nature 417(6892):949\u2013954","journal-title":"Nature"},{"key":"2109_CR30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/1477-3163.126759","volume":"13","author":"A Jarkowski 3rd","year":"2014","unstructured":"Jarkowski A 3rd, Khushalani NI (2014) BRAF and beyond: tailoring strategies for the individual melanoma patient. J Carcinog 13:1. doi: 10.4103\/1477-3163.126759","journal-title":"J Carcinog"},{"issue":"24","key":"2109_CR31","doi-asserted-by":"crossref","first-page":"6696","DOI":"10.1158\/1078-0432.CCR-13-1746","volume":"19","author":"KE Hutchinson","year":"2013","unstructured":"Hutchinson KE, Lipson D, Stephens PJ, Otto G, Lehmann BD, Lyle PL, Vnencak-Jones CL, Ross JS, Pietenpol JA, Sosman JA, Puzanov I, Miller VA, Pao W (2013) BRAF fusions define a distinct molecular subset of melanomas with potential sensitivity to MEK inhibition. Clin Cancer Res 19(24):6696\u20136702","journal-title":"Clin Cancer Res"},{"issue":"9861","key":"2109_CR32","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(12)61134-9","volume":"381","author":"DN Franz","year":"2013","unstructured":"Franz DN, Belousova E, Sparagana S, Bebin EM, Frost M, Kuperman R, Witt O, Kohrman MH, Flamini JR, Wu JY, Curatolo P, de Vries PJ, Whittemore VH, Thiele EA, Ford JP, Shah G, Cauwel H, Lebwohl D, Sahmoud T, Jozwiak S (2013) Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial. Lancet 381(9861):125\u2013132","journal-title":"Lancet"},{"issue":"suppl 3","key":"2109_CR33","doi-asserted-by":"crossref","first-page":"iii27","DOI":"10.1093\/neuonc\/nou208.15","volume":"16","author":"MW Kieran","year":"2014","unstructured":"Kieran MW, Yao X, Macy M, Leary S, Cohen K, MacDonald T et al (2014) Final results of a prospective multi-institutional phase II study of everolimus (RAD001), an mTOR inhibitor, in pediatric patients with recurrent or progressive low-grade glioma. A POETIC consortium trial. Neuro Oncol 16(suppl 3):iii27","journal-title":"A POETIC consortium trial. Neuro Oncol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-016-2109-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-016-2109-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-016-2109-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:23:00Z","timestamp":1559348580000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-016-2109-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,19]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["2109"],"URL":"https:\/\/doi.org\/10.1007\/s11060-016-2109-x","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,19]]}}}